Limin Xia
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
Papers in
-
- Cancer-related molecular mechanisms research 11
- Cancer, Hypoxia, and Metabolism 11
-
- RNA modifications and cancer 18
- Epigenetics and DNA Methylation 14
- FOXO transcription factor regulation 12
- Cancer-related gene regulation 9
- Co-authors
- Wenjie Huang (43 shared papers)Kaichun Wu (36 shared papers)Dean Tian (27 shared papers)Daiming Fan (23 shared papers)Yongzhan Nie (27 shared papers)Yijun Wang (24 shared papers)Tongyue Zhang (22 shared papers)Danfei Liu (20 shared papers)
- Journals
- Theranostics (8 papers)Gastroenterology (6 papers)Oncogene (5 papers)Hepatology (5 papers)Cancer Cell (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Limin Xia
141 papers receiving 5.0k citations
Limin Xia's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 1.2k
- Oncology 1.1k
- Molecular Biology 2.7k
- Immunology 740
- Hepatology 221
Countries citing papers authored by Limin Xia
This map shows the geographic impact of Limin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limin Xia more than expected).
Fields of papers citing papers by Limin Xia
This network shows the impact of papers produced by Limin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limin Xia. The network helps show where Limin Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Limin Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 273 | |
| 2 | 2012 | 174 | |
| 3 | 2016 | 164 | |
| 4 | FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2 Hit paper breakdown → | 2023 | 157 |
| 5 | 2017 | 149 | |
| 6 | 2021 | 138 | |
| 7 | 2013 | 133 | |
| 8 | 2012 | 132 | |
| 9 | 2015 | 121 | |
| 10 | 2017 | 119 | |
| 11 | 2019 | 119 | |
| 12 | Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion Hit paper breakdown → | 2024 | 115 |
| 13 | 2012 | 104 | |
| 14 | 2015 | 102 | |
| 15 | 2013 | 100 | |
| 16 | 2012 | 97 | |
| 17 | 2019 | 97 | |
| 18 | 2018 | 95 | |
| 19 | 2018 | 89 | |
| 20 | 2009 | 80 |
About Limin Xia
Limin Xia is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Cardiology and Cardiovascular Medicine, having authored 149 papers that have together received 5.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Epigenetics and DNA Methylation (14 papers), Immune cells in cancer (12 papers), FOXO transcription factor regulation (12 papers), Cancer-related molecular mechanisms research (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cancer-related gene regulation (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.1k citations), Molecular Biology (2.7k citations), Immunology (740 citations) and Hepatology (221 citations). Limin Xia has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wenjie Huang, Kaichun Wu, Dean Tian, Daiming Fan, Yongzhan Nie, Yijun Wang, Tongyue Zhang, Danfei Liu, Mengyu Sun and Zhangqian Chen. Their work appears in journals such as Theranostics, Gastroenterology, Oncogene, Hepatology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.